Daniel Spangholm is a Senior Scientist in Bioanalysis at Adcendo, where they are currently enhancing bioanalytical methodologies. Previously, they held similar roles at LEO Pharma and Novo Nordisk, specializing in the development, optimization, and validation of ligand binding assays for both non-clinical studies and clinical trials. Daniel earned a Master of Science Engineering in Biotechnology and a Bachelor of Engineering in Chemistry from the Technical University of Denmark. Their extensive experience includes analyzing bioanalytical samples and overseeing assay validations, particularly in GLP and GCP environments.
This person is not in the org chart
This person is not in any teams
This person is not in any offices